2. Apoptosis Cell Cycle/DNA Damage
  3. CDK Apoptosis
  4. CDK9-IN-24

CDK9-IN-24 (compound 21a) is a highly selective CDK9 inhibitor with significant inhibitory effect on tumor growth. CDK9-IN-24 effectively blocks cell proliferation and induces apoptosis by downregulating Mcl-1 and c-Myc, and can be used in acute myeloid leukemia research.

For research use only. We do not sell to patients.

CDK9-IN-24

CDK9-IN-24 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

CDK9-IN-24 Related Antibodies

Top Publications Citing Use of Products

View All CDK Isoform Specific Products:

View All Isoforms
CDK1 CDK2 CDK3 CDK4 CDK5 CDK6 CDK7 CDK8 CDK9 CDK11 CDK12 CDK13 CDK14 CDK16 CDK19 CDC CLK Pho85 CDK10 CDK15 CDK17 CDK18 CDK20 PITSLRE

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

CDK9-IN-24 (compound 21a) is a highly selective CDK9 inhibitor with significant inhibitory effect on tumor growth. CDK9-IN-24 effectively blocks cell proliferation and induces apoptosis by downregulating Mcl-1 and c-Myc, and can be used in acute myeloid leukemia research[1].

IC50 & Target

CDK9

 

Cellular Effect
Cell Line Type Value Description References
A549 IC50
0.7 μM
Compound: 21a
Antiproliferative activity against human A549 cells assessed as reduction in cell viability measured after 72 hrs
Antiproliferative activity against human A549 cells assessed as reduction in cell viability measured after 72 hrs
[PMID: 37572539]
BT-549 IC50
0.21 μM
Compound: 21a
Antiproliferative activity against human BT-549 cells assessed as reduction in cell viability measured after 72 hrs
Antiproliferative activity against human BT-549 cells assessed as reduction in cell viability measured after 72 hrs
[PMID: 37572539]
CWR22R IC50
1.25 μM
Compound: LWT-111
Antiproliferative activity against human 22Rv1 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
Antiproliferative activity against human 22Rv1 cells assessed as reduction in cell viability incubated for 72 hrs by SRB assay
[PMID: 37672930]
HCT-116 IC50
0.02 μM
Compound: 21a
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability measured after 72 hrs
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability measured after 72 hrs
[PMID: 37572539]
HEK293 IC50
10.7 μM
Compound: 21a
Cytotoxicity against human HEK293 cells assessed as reduction in cell viability measured after 72 hrs
Cytotoxicity against human HEK293 cells assessed as reduction in cell viability measured after 72 hrs
[PMID: 37572539]
HL-60 IC50
0.18 μM
Compound: 21a
Antiproliferative activity against human HL-60 cells assessed as reduction in cell viability measured after 72 hrs
Antiproliferative activity against human HL-60 cells assessed as reduction in cell viability measured after 72 hrs
[PMID: 37572539]
HT-29 IC50
1.06 μM
Compound: 21a
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability measured after 72 hrs
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability measured after 72 hrs
[PMID: 37572539]
HepG2 IC50
0.41 μM
Compound: 21a
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability measured after 72 hrs
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability measured after 72 hrs
[PMID: 37572539]
L02 IC50
10.6 μM
Compound: 21a
Cytotoxicity against human L02 cells assessed as reduction in cell viability measured after 72 hrs
Cytotoxicity against human L02 cells assessed as reduction in cell viability measured after 72 hrs
[PMID: 37572539]
MCF7 IC50
0.14 μM
Compound: 21a
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability measured after 72 hrs
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability measured after 72 hrs
[PMID: 37572539]
MOLM-13 IC50
0.16 μM
Compound: 21a
Antiproliferative activity against human MOLM-13 cells assessed as reduction in cell viability measured after 72 hrs
Antiproliferative activity against human MOLM-13 cells assessed as reduction in cell viability measured after 72 hrs
[PMID: 37572539]
MV4-11 IC50
0.06 μM
Compound: 21a
Antiproliferative activity against human MV4-11 cells assessed as reduction in cell viability measured after 72 hrs
Antiproliferative activity against human MV4-11 cells assessed as reduction in cell viability measured after 72 hrs
[PMID: 37572539]
SW480 IC50
3.45 μM
Compound: 21a
Antiproliferative activity against human SW480 cells assessed as reduction in cell viability measured after 72 hrs
Antiproliferative activity against human SW480 cells assessed as reduction in cell viability measured after 72 hrs
[PMID: 37572539]
THP-1 IC50
0.45 μM
Compound: 21a
Antiproliferative activity against human THP-1 cells assessed as reduction in cell viability measured after 72 hrs
Antiproliferative activity against human THP-1 cells assessed as reduction in cell viability measured after 72 hrs
[PMID: 37572539]
Molecular Weight

461.55

Formula

C27H31N3O4
SMILES

CN(CC1)CC=C1C2=C3C(C(C=C(C4=CC=C(N5CCN(C)CC5)C=C4)O3)=O)=C(O)C=C2OC
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

CDK9-IN-24 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

CDK9-IN-24CDKApoptosisCyclin dependent kinaseCDK9 inhibitorInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
CDK9-IN-24
Cat. No.:
HY-155153
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.